<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: Guidelines recommend periodic endoscopic surveillance of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) patients to detect and treat early esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>; however, no trials or population-based studies exist </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the association between endoscopic surveillance of BE and survival among esophageal/gastric cardia <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We studied a cohort of 23 BE patients, among 589 esophageal or gastric cardia <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> patients diagnosed between 1990-1998 at Northern California Kaiser Permanente (a large health maintenance organization) </plain></SENT>
<SENT sid="3" pm="."><plain>We measured the presence of BE, detection of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> by endoscopic surveillance, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stage, mortality, and potential confounders </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: BE was diagnosed in 135 of 589 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> patients, with 23 BE patients diagnosed greater than 6 months before <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was diagnosed </plain></SENT>
<SENT sid="5" pm="."><plain>Among these 23 patients, 73% of the surveillance-detected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients (n = 15) were alive at the end of follow-up, compared with none of the patients without surveillance-detected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (n = 8; P = 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> surveillance-detected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients had low-stage disease and none died directly from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The surveillance/survival association was not substantially altered by stratification for age at BE diagnosis or other potential confounders </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Surveillance-detected BE-associated <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> were associated with low-stage disease and improved survival </plain></SENT>
<SENT sid="9" pm="."><plain>Additional studies are needed to evaluate potential biases and whether screening/surveillance programs decrease mortality among <z:hpo ids='HP_0000001'>all</z:hpo> patients in surveillance </plain></SENT>
<SENT sid="10" pm="."><plain>Few patients (3.9%) had a BE diagnosed before their <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, even if current surveillance techniques are effective, they are unlikely to substantially impact the population's mortality from <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>; better methods are needed to identify at risk patients </plain></SENT>
</text></document>